nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—Liver function test abnormal—Melphalan—peripheral nervous system neoplasm	0.0254	0.0254	CcSEcCtD
Milrinone—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.0237	0.0237	CcSEcCtD
Milrinone—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.0237	0.0237	CcSEcCtD
Milrinone—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.0234	0.0234	CcSEcCtD
Milrinone—Liver function test abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0211	0.0211	CcSEcCtD
Milrinone—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.018	0.018	CcSEcCtD
Milrinone—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Milrinone—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Milrinone—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Milrinone—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.017	0.017	CcSEcCtD
Milrinone—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.0164	0.0164	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.0159	0.0159	CcSEcCtD
Milrinone—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.0157	0.0157	CcSEcCtD
Milrinone—Tremor—Tretinoin—peripheral nervous system neoplasm	0.0157	0.0157	CcSEcCtD
Milrinone—Chest pain—Topotecan—peripheral nervous system neoplasm	0.0144	0.0144	CcSEcCtD
Milrinone—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.0143	0.0143	CcSEcCtD
Milrinone—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.0143	0.0143	CcSEcCtD
Milrinone—Chest pain—Melphalan—peripheral nervous system neoplasm	0.0141	0.0141	CcSEcCtD
Milrinone—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.0141	0.0141	CcSEcCtD
Milrinone—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.014	0.014	CcSEcCtD
Milrinone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.0138	0.0138	CcSEcCtD
Milrinone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0137	0.0137	CcSEcCtD
Milrinone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0137	0.0137	CcSEcCtD
Milrinone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0135	0.0135	CcSEcCtD
Milrinone—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.0135	0.0135	CcSEcCtD
Milrinone—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.0134	0.0134	CcSEcCtD
Milrinone—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.0134	0.0134	CcSEcCtD
Milrinone—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Milrinone—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.0131	0.0131	CcSEcCtD
Milrinone—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Milrinone—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Milrinone—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Milrinone—Hypotension—Melphalan—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Milrinone—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.0118	0.0118	CcSEcCtD
Milrinone—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Milrinone—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Milrinone—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Milrinone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0104	0.0104	CcSEcCtD
Milrinone—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Milrinone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Milrinone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Milrinone—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00981	0.00981	CcSEcCtD
Milrinone—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00971	0.00971	CcSEcCtD
Milrinone—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00936	0.00936	CcSEcCtD
Milrinone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00886	0.00886	CcSEcCtD
Milrinone—Rash—Topotecan—peripheral nervous system neoplasm	0.00872	0.00872	CcSEcCtD
Milrinone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00871	0.00871	CcSEcCtD
Milrinone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00867	0.00867	CcSEcCtD
Milrinone—Headache—Topotecan—peripheral nervous system neoplasm	0.00866	0.00866	CcSEcCtD
Milrinone—Rash—Tretinoin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Milrinone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Milrinone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00864	0.00864	CcSEcCtD
Milrinone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00864	0.00864	CcSEcCtD
Milrinone—Headache—Tretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Milrinone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Milrinone—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00855	0.00855	CcSEcCtD
Milrinone—Rash—Melphalan—peripheral nervous system neoplasm	0.00854	0.00854	CcSEcCtD
Milrinone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00853	0.00853	CcSEcCtD
Milrinone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00847	0.00847	CcSEcCtD
Milrinone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00842	0.00842	CcSEcCtD
Milrinone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00828	0.00828	CcSEcCtD
Milrinone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00812	0.00812	CcSEcCtD
Milrinone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00795	0.00795	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00791	0.00791	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00779	0.00779	CcSEcCtD
Milrinone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00779	0.00779	CcSEcCtD
Milrinone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00758	0.00758	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00721	0.00721	CcSEcCtD
Milrinone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Milrinone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Milrinone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00655	0.00655	CcSEcCtD
Milrinone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Milrinone—Rash—Vincristine—peripheral nervous system neoplasm	0.00632	0.00632	CcSEcCtD
Milrinone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00631	0.00631	CcSEcCtD
Milrinone—Headache—Vincristine—peripheral nervous system neoplasm	0.00628	0.00628	CcSEcCtD
Milrinone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Milrinone—Rash—Cisplatin—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Milrinone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00558	0.00558	CcSEcCtD
Milrinone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00529	0.00529	CcSEcCtD
Milrinone—Rash—Etoposide—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Milrinone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00511	0.00511	CcSEcCtD
Milrinone—Headache—Etoposide—peripheral nervous system neoplasm	0.00508	0.00508	CcSEcCtD
Milrinone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00475	0.00475	CcSEcCtD
Milrinone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Milrinone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00445	0.00445	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Milrinone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00425	0.00425	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Milrinone—Rash—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Milrinone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Milrinone—Headache—Epirubicin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Milrinone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Milrinone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
